- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07761299
Versius Robotic Surgery in the NHS: A Multi-Specialty Retrospective Study
August 7, 2026 updated by: CMR Surgical Ltd
Robotic-Assisted Surgery With Versius in the NHS: Retrospective Comparative Performance Study Across Multiple Soft-Tissue Specialties
To generate robust, real-world comparative evidence on the short and long-term clinical outcomes following surgical intervention with Versius Robot-Assisted Surgery versus surgical standard of care across predefined soft-tissue index procedures in routine NHS practice.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
1200
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing soft-tissue surgical procedures using the Versius Surgical System or a comparator surgical approach (laparoscopic or open surgery).
Description
Inclusion Criteria:
- Patients undergoing one of the index procedures with Versius, laparoscopically or with open surgery.
- Patients who provide written consent (16 years or older) or for whom an appropriate legal representative who provides written informed consent (<16 years old).
Exclusion Criteria:
- Patients participating in an interventional clinical study that might impact the defined endpoints.
- Patients undergoing concomitant surgery.
- Patients or appropriate legal representatives unwilling to provide written consent.
- Patients with BMI at or above 40 kg/m2.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Versius Robotic-Assisted Surgery
Patients undergoing soft-tissue surgical procedures using the Versius Surgical System
|
|
Non-Versius Surgical Cohort
Patients undergoing comparable soft-tissue surgical procedures using non-Versius surgical approaches (conventional laparoscopic and open surgery).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Procedure related complication rates
Time Frame: Within 30 days and 12 months after surgery
|
Rate of total procedure related complications within 30 days and up to 12 months following surgery
|
Within 30 days and 12 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of hospital stay
Time Frame: Up to post-surgical discharge, i.e. the date when patient is considered sufficiently recovered from surgery to leave hospital, expected to be at most up to 1 month after date of surgery, typically within a few days
|
Hospital stay in days from day of surgery until discharge
|
Up to post-surgical discharge, i.e. the date when patient is considered sufficiently recovered from surgery to leave hospital, expected to be at most up to 1 month after date of surgery, typically within a few days
|
|
Operative time
Time Frame: Up to completion of surgery
|
Surgical time from skin incision to skin closure
|
Up to completion of surgery
|
|
Conversion rate
Time Frame: Up to completion of surgery
|
Proportion of surgical procedures requiring unplanned conversion to conventional laparoscopic or open surgery.
|
Up to completion of surgery
|
|
Revision surgery rate
Time Frame: Within 12 months following surgery
|
Proportion of participants requiring revision surgery within 12 months following the index surgical procedure.
Revision surgery is defined as any subsequent surgical procedure required as a result of the index surgical procedure or the underlying condition for which the index surgical procedure was performed.
|
Within 12 months following surgery
|
|
Rate of pre-defined index procedure specific complications
Time Frame: Within 30 days and 12 months after surgery
|
Percentage of participants who experience one or more pre-defined procedure-specific complications related to the index surgical procedure
|
Within 30 days and 12 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
August 1, 2026
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
August 4, 2026
First Submitted That Met QC Criteria
August 7, 2026
First Posted (Actual)
August 12, 2026
Study Record Updates
Last Update Posted (Actual)
August 12, 2026
Last Update Submitted That Met QC Criteria
August 7, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- CA-00671
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.